ULRICH PERREY

Coronavirus drug remdesivir to cost $3,120 per patient on private insurance

From www.nydailynews.com
By
Nelson Oliveira
ULRICH PERREY

The Ebola drug that has been confirmed to work against coronavirus will cost U.S. hospitals at least $3,120 per patient with private insurance, manufacturer Gilead Sciences announced Monday. Remdesivir, the only drug with emergency approval to treat COVID-19, has been found to reduce recovery time by an average of four days among patients who are sick enough to be hospitalized.